Eden Research (LON:EDEN) Trading Up 26.5% – Should You Buy?

Eden Research plc (LON:EDEN)’s share price was up 26.5% on Wednesday . The company traded as high as GBX 3.48 ($0.05) and last traded at GBX 3.48 ($0.05). Approximately 778,726 shares traded hands during trading, an increase of 16% from the average daily volume of 670,749 shares. The stock had previously closed at GBX 2.75 ($0.04).

Eden Research Price Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The business has a 50-day moving average price of GBX 2.82 and a two-hundred day moving average price of GBX 3.44. The firm has a market capitalization of £21.33 million, a price-to-earnings ratio of -14.01 and a beta of 0.92.

Eden Research (LON:EDEN) last announced its quarterly earnings results on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) earnings per share for the quarter. Eden Research had a negative return on equity of 11.63% and a negative net margin of 38.70%. As a group, research analysts forecast that Eden Research plc will post -66.0000038 EPS for the current year.

Insider Buying and Selling

In other Eden Research news, insider Sean M. Smith acquired 426,986 shares of the firm’s stock in a transaction that occurred on Tuesday, April 1st. The stock was acquired at an average cost of GBX 234 ($3.11) per share, with a total value of £999,147.24 ($1,329,714.19). Also, insider Alexander John Abrey acquired 167,947 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,705.36). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.